A systematic review of matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry compared to routine microbiological methods for the time taken to identify microbial organisms from positive blood cultures

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 5, 2015, Pages 863-876

  Dixon, P ^a   Davies, P ^a   Hollingworth, W ^a   Stoddart, M ^b   MacGowan, A ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; COMPARATIVE STUDY; ECONOMICS; HEALTH CARE COST; HUMAN; LENGTH OF STAY; MASS SPECTROMETRY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROCEDURES; SEPSIS; TIME;

BLOOD; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; MICROBIOLOGICAL TECHNIQUES; SEPSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 84939957979     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2322-0     Document Type: Review

References (40)

1. Centers for Disease Control and Prevention (CDC) (2014) CDC/NHSN surveillance definitions for specific types of infections. CDC, 63 pp
2. Seifert H (2009) The clinical importance of microbiological findings in the diagnosis and management of bloodstream infections. Clin Infect Dis 48(Suppl 4):S238–S245
3. Bearman GML, Wenzel RP (2005) Bacteremias: a leading cause of death. Arch Med Res 36(6):646–659
4. Goto M, Al-Hasan MN (2013) Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect 19(6):501–509
5. Olaechea PM, Palomar M, Álvarez-Lerma F, Otal JJ, Insausti J, López-Pueyo MJ; ENVIN-HELICS Group (2013) Morbidity and mortality associated with primary and catheter-related bloodstream infections in critically ill patients. Rev Esp Quimioter 26(1):21–29
6. Laupland KB, Gregson DB, Flemons WW, Hawkins D, Ross T, Church DL (2007) Burden of community-onset bloodstream infection: a population-based assessment. Epidemiol Infect 135(6):1037–1042
7. Kilgore M, Brossette S (2008) Cost of bloodstream infections. Am J Infect Control 36(10):S172.e1–S172.e3
8. Lenz R, Leal JR, Church DL, Gregson DB, Ross T, Laupland KB (2012) The distinct category of healthcare associated bloodstream infections. BMC Infect Dis 12:85
9. Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SRLJ, McDougall C, Wilcox MH (2007) epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 65(Suppl 1):S1–S64
10. National Institute for Health and Care Excellence (NICE) (2012) Prevention and control of healthcare-associated infections in primary and community care. Available online at: http://www.nice.org.uk/guidance/cg139/resources/guidance-infection-pdf. Accessed 25 July 2014
11. Vallés J, Ferrer R (2009) Bloodstream infection in the ICU. Infect Dis Clin North Am 23(3):557–569
12. Tonolla M, Benagli C, Rossi V, Fragoso C, Petrini O (2010) MALDI-TOF MS: a new laboratory option for the diagnosis of clinical infections. Pipette 3:6–10
13. Kok J, Thomas LC, Olma T, Chen SC, Iredell JR (2011) Identification of bacteria in blood culture broths using matrix-assisted laser desorption–ionization Sepsityper™ and time of flight mass spectrometry. PLoS One 6(8):e23285
14. Jacquier H, Carbonnelle E, Corvec S, Illiaquer M, Le Monnier A, Bille E, Zahar JR, Beretti JL, Jauréguy F, Fihman V, Tankovic J, Cattoir V (2011) Revisited distribution of nonfermenting Gram-negative bacilli clinical isolates. Eur J Clin Microbiol Infect Dis 30(12):1579–1586
15. Fournier P-E, Drancourt M, Colson P, Rolain J-M, La Scola B, Raoult D (2013) Modern clinical microbiology: new challenges and solutions. Nat Rev Microbiol 11(8):574–585
16. Afshari A, Schrenzel J, Ieven M, Harbarth S (2012) Bench-to-bedside review: rapid molecular diagnostics for bloodstream infection—a new frontier? Crit Care 16(3):222
17. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL (2011) Performance and cost analysis of matrix-assisted laser desorption ionization–time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol 49(4):1614–1616
18. Canadian Agency for Drugs and Technologies in Health (2011) MALDI-TOF mass spectrometry for bacterial species identification: a review of diagnostic accuracy and clinical and cost-effectiveness. Rapid Response Rep. Available online at: http://www.cadth.ca/en/publication/2936
19. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100
20. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JAC; Cochrane Bias Methods Group; Cochrane Statistical Methods Group (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928
21. Centre for Reviews and Dissemination (2009) Systematic reviews: CRD’s guidance for undertaking systematic reviews in health care. University of York, York
22. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, Peterson LE, Musser JM (2013) Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 137(9):1247–1254
23. Buchan BW, Riebe KM, Ledeboer NA (2012) Comparison of the MALDI Biotyper system using Sepsityper specimen processing to routine microbiological methods for identification of bacteria from positive blood culture bottles. J Clin Microbiol 50(2):346–352
24. Jamal W, Saleem R, Rotimi VO (2013) Rapid identification of pathogens directly from blood culture bottles by Bruker matrix-assisted laser desorption laser ionization–time of flight mass spectrometry versus routine methods. Diagn Microbiol Infect Dis 76(4):404–408
25. Lagacé-Wiens PRS, Adam HJ, Karlowsky JA, Nichol KA, Pang PF, Guenther J, Webb AA, Miller C, Alfa MJ (2012) Identification of blood culture isolates directly from positive blood cultures by use of matrix-assisted laser desorption ionization–time of flight mass spectrometry and a commercial extraction system: analysis of performance, cost, and turnaround time. J Clin Microbiol 50(10):3324–3328
26. Leli C, Cenci E, Cardaccia A, Moretti A, D’Alò F, Pagliochini R, Barcaccia M, Farinelli S, Vento S, Bistoni F, Mencacci A (2013) Rapid identification of bacterial and fungal pathogens from positive blood cultures by MALDI-TOF MS. Int J Med Microbiol 303(4):205–209
27. Martiny D, Debaugnies F, Gateff D, Gérard M, Aoun M, Martin C, Konopnicki D, Loizidou A, Georgala A, Hainaut M, Chantrenne M, Dediste A, Vandenberg O, Van Praet S (2013) Impact of rapid microbial identification directly from positive blood cultures using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry on patient management. Clin Microbiol Infect 19(12):E568–E581
28. Machen A, Drake T, Wang YF (2014) Same day identification and full panel antimicrobial susceptibility testing of bacteria from positive blood culture bottles made possible by a combined lysis-filtration method with MALDI-TOF VITEK mass spectrometry and the VITEK2 system. PLoS One 9(2):e87870
29. Schneiderhan W, Grundt A, Wörner S, Findeisen P, Neumaier M (2013) Work flow analysis of around-the-clock processing of blood culture samples and integrated MALDI-TOF mass spectrometry analysis for the diagnosis of bloodstream infections. Clin Chem 59(11):1649–1656
30. De Bel A, Wybo I, Vandoorslaer K, Rosseel P, Lauwers S, Piérard D (2011) Acceptance criteria for identification results of Gram-negative rods by mass spectrometry. J Med Microbiol 60(Pt 5):684–686
31. Martiny D, Dediste A, Vandenberg O (2012) Comparison of an in-house method and the commercial Sepsityper™ kit for bacterial identification directly from positive blood culture broths by matrix-assisted laser desorption–ionisation time-of-flight mass spectrometry. Eur J Clin Microbiol Infect Dis 31(9):2269–2281
32. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL (2013) Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 57(9):1237–1245
33. Hennekens CH, Buring JE (1987) Epidemiology in medicine. Little, Brown and Company, Boston
34. Vlek ALM, Bonten MJM, Boel CHE (2012) Direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry improves appropriateness of antibiotic treatment of bacteremia. PLoS One 7(3):e32589
35. U.S. Food and Drug Administration (FDA) (2013) New test system identifies 193 different yeasts and bacteria known to cause illness. Available online at: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm365907.htm. Accessed 28 May 2014
36. Chen JHK, Ho P-L, Kwan GSW, She KKK, Siu GKH, Cheng VCC, Yuen K-Y, Yam W-C (2013) Direct bacterial identification in positive blood cultures by use of two commercial matrix-assisted laser desorption ionization–time of flight mass spectrometry systems. J Clin Microbiol 51(6):1733–1739
37. Cherkaoui A, Hibbs J, Emonet S, Tangomo M, Girard M, Francois P, Schrenzel J (2010) Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J Clin Microbiol 48(4):1169–1175
38. Neville SA, LeCordier A, Ziochos H, Chater MJ, Gosbell IB, Maley MW, van Hal SJ (2011) Utility of matrix-assisted laser desorption ionization–time of flight mass spectrometry following introduction for routine laboratory bacterial identification. J Clin Microbiol 49(8):2980–2984
39. Seng P, Drancourt M, Gouriet F, La Scola B, Fournier P-E, Rolain JM, Raoult D (2009) Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 49(4):543–551
40. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL (2005) Methods for the economic evaluation of health care programmes, 3rd edn. Oxford University Press, New York